RxDoctor Payments Data

Steven Thore, MD

Addiction Psychiatry · Hopkinsville, KYNPI 1013113745

Payments from drug & device makers

$639in general payments, 2019–2025

Across 35 payments — averaging $18.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$256
  • Johnson & Johnson$136
  • Otsuka America Pharmaceutical, Inc.$58
  • Alkermes, Inc.$42
  • Lundbeck LLC$36
  • Vanda Pharmaceuticals Inc.$33
  • plus $78 from 4 others

What the payments were for

  • Food & beverage$639100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few addiction psychiatry providers in Kentuckyto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$6,263
Medicare patients
31
Services billed
76

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl40$59,430
Invega SustennaPaliperidone Palmitate11$35,885
TrintellixVortioxetine Hydrobromide16$9,842
DayvigoLemborexant14$4,485
Gabapentin312$4,356
Asenapine Maleate11$3,710
Lurasidone Hcl32$3,181
Doxepin Hcl70$1,910
Aripiprazole101$1,810
Quetiapine Fumarate124$1,335
Mirtazapine109$1,204
Olanzapine OdtOlanzapine12$1,198
Baclofen63$1,178
Hydroxyzine Hcl116$970
Ziprasidone Hcl26$866

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$15$59,43040 claims
Johnson & JohnsonInvega Sustenna$136$35,88511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few addiction psychiatry providers in Kentuckyon file to place this against a meaningful peer group, so we don't.

Other addiction psychiatry in Hopkinsville

Where these figures come from

Is this you, or does something look wrong? →